Researchers at the National Institutes of Health (NIH) and their collaborators have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface. Mutant RAS, they found, helps to kick off a series of events involving the transport of specific nuclear proteins that lead to uncontrolled tumor growth, according to a study published November 11, 2024, in Nature Cancer.

In a paper published in Science China Life Sciences, professor Wang Guoqing's team at Jilin University conducted single-cell sequencing analysis on right ventricular free wall tissue from healthy donors and patients with characteristic coagulation abnormalities of COVID-19, revealing the mechanism of cardiac microthrombosis formation in patients after SARS-CoV-2 infection.

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles (EVs) loaded with customisable anti-cancer antisense oligonucleotides suppressed cancer growth.